Recognizing the transformative potential of psychedelic medicines, we leverage research and market data to lead multi-stakeholder strategic processes to anticipate, mitigate, and respond to psychedelic harms and improve patient outcomes. We have three core functions which are carried out in parallel, and all are done in deep relationship and iterative feedback with the broader ecosystem.